Medidata beefs up CRO ties with China partnership

Medidata Solutions ($MDSO) has been on a well-documented hunt for new business from CROs that are modernizing their methods of managing clinical trials data and taking a greater share of the clinical development market. Now the New York-based provider of clinical trials software is expanding its CRO connections in China, where Shanghai-based Tigermed Consulting has become the first Chinese contract researcher to join Medidata's partner program. Tigermed, which has 39 offices across China, plans to initially use Medidata's hosted electronic data capture (EDC) and clinical trial management system (CTMS) platform, called Rave, for Phase III trials, according to Medidata's release. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.